Brain Cell-based Genetic Subtyping and Drug Repositioning for Alzheimer Disease
Sahelijo, N.; Rajagopalan, P.; Qian, L.; Rahman, R.; Priyadarshi, D.; Goldstein, D.; Thomopoulos, S. I.; Bennett, D. A.; Farrer, L. A.; Stein, T. D.; AI4AD Consortium, ; Shen, L.; Huang, H.; Nho, K.; Andrew, S. J.; Davatzikos, C.; Thompson, P. M.; TCW, J.; Jun, G. R.
Show abstract
Alzheimers Disease (AD) is characterized by its complex and heterogeneous etiology and gradual progression, leading to high drug failure rates in late-stage clinical trials. In order to better stratify individuals at risk for AD and discern potential therapeutic targets we employed a novel procedure utilizing cell-based co-regulated gene networks and polygenic risk scores (cbPRSs). After defining genetic subtypes using extremes of cbPRS distributions, we evaluated correlations of the genetic subtypes with previously defined AD subtypes defined on the basis of domain-specific cognitive functioning and neuroimaging biomarkers. Employing a PageRank algorithm, we identified priority gene targets for the genetic subtypes. Pathway analysis of priority genes demonstrated associations with neurodegeneration and suggested candidate drugs currently utilized in diabetes, hypertension, and epilepsy for repositioning in AD. Experimental validation utilizing human induced pluripotent stem cell (hiPSC)-derived astrocytes demonstrated the modifying effects of estradiol, levetiracetam, and pioglitazone on expression of APOE and complement C4 genes, suggesting potential repositioning for AD.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- A public resource of single cell transcriptomes and multiscale networks from persons with and without Alzheimer's disease 97%
- Deep clinical phenotyping of Alzheimer’s Disease Patients Leveraging Electronic Medical Records Data Identifies Sex-Specific Clinical Associations 97%
- DNA methylation signatures of Alzheimer's disease neuropathology in the cortex are primarily driven by variation in non-neuronal cell-types 96%
Similar papers in this journal
- African Ancestry GWAS of Dementia in a Large Military Cohort Identifies Significant Risk Loci 97%
- Region-based analysis of rare genomic variants in whole-genome sequencing datasets reveal two novel Alzheimer’s disease-associated genes: DTNB and DLG2 97%
- Integrative Brain Transcriptome Analysis Links Complement Component 4 and HSPA2 to the APOE ε2 Protective Effect in Alzheimer Disease 97%
Similar papers in this journal
- A Specialized Reference Panel with Structural Variants Integration for Improving Genotype Imputation in Alzheimer's Disease and Related Dementias (ADRD) 95%
- The genetic architecture of Alzheimer disease risk in the Ohio and Indiana Amish 95%
- Transcriptome-wide analyses delineate the genetic architecture of expression variation in atopic dermatitis 94%